A Comparison of Self-Reported Analgesic Use and Detection of Urinary Ibuprofen and Acetaminophen Metabolites by Means of Metabonomics: The INTERMAP Study
Authors:
- Ruey Leng LooRuey Leng Loo
- Queenie ChanQCQueenie Chan
- Ian J. BrownIBIan J. Brown
- Claire E. RobertsonCRClaire E. Robertson
- Jeremiah StamlerJSJeremiah Stamler
- Jeremy K. NicholsonJNJeremy K. Nicholson
- Elaine HolmesEHElaine Holmes
- Paul ElliottPEPaul Elliott
- for the INTERMAP Research GroupFGfor the INTERMAP Research Group
Open Access
- 5 January 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 175 (4) , 348-358
Abstract
Information on dietary supplements, medications, and other xenobiotics in epidemiologic surveys is usually obtained from questionnaires and is subject to recall and reporting biases. The authors used metabolite data obtained from hydrogen-1 (or proton) nuclear magnetic resonance (1H NMR) analysis of human urine specimens from the International Study of Macro-/Micro-Nutrients and Blood Pressure (INTERMAP Study) to validate self-reported analgesic use. Metabolic profiling of two 24-hour urine specimens per individual was carried out for 4,630 participants aged 40–59 years from 17 population samples in Japan, China, the United Kingdom, and the United States (data collection, 1996–1999). 1H NMR-detected acetaminophen and ibuprofen use was low (∼4%) among East Asian population samples and higher (>16%) in Western population samples. In a comparison of self-reported acetaminophen and ibuprofen use with 1H NMR-detected acetaminophen and ibuprofen metabolites among 496 participants from Chicago, Illinois, and Belfast, Northern Ireland, the overall rate of concordance was 81%–84%; the rate of underreporting was 15%–17%; and the rate of underdetection was approximately 1%. Comparison of self-reported unspecified analgesic use with 1H NMR-detected acetaminophen and ibuprofen metabolites among 2,660 Western INTERMAP participants revealed similar levels of concordance and underreporting. Screening for urinary metabolites of acetaminophen and ibuprofen improved the accuracy of exposure information. This approach has the potential to reduce recall bias and other biases in epidemiologic studies for a range of substances, including pharmaceuticals, dietary supplements, and foods.Keywords
This publication has 47 references indexed in Scilit:
- Questionnaire-based self-reported nutrition habits associate with serum metabolism as revealed by quantitative targeted metabolomicsEuropean Journal of Epidemiology, 2010
- Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological SettingPLOS ONE, 2010
- Epidemiology of OsteoarthritisClinics in Geriatric Medicine, 2010
- Metabolic profiling strategy for discovery of nutritional biomarkers: proline betaine as a marker of citrus consumptionThe American Journal of Clinical Nutrition, 2010
- Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy IndividualsCirculation: Cardiovascular Quality and Outcomes, 2010
- The role of paracetamol in the pathogenesis of asthmaClinical & Experimental Allergy, 2009
- Prenatal Exposure to Acetaminophen and Asthma in ChildrenObstetrics & Gynecology, 2009
- Metabolic Profiling and Population Screening of Analgesic Usage in Nuclear Magnetic Resonance Spectroscopy-Based Large-Scale Epidemiologic StudiesAnalytical Chemistry, 2009
- Information on drug use in the elderly: A comparison of pharmacy, general- practitioner and patient dataPharmacy World & Science, 1995
- Comparison of questionnaire information and pharmacy data on drug useInternational Journal of Clinical Pharmacy, 1991